Solid Cancers 2

BIOL66531 Solid Cancers 2 15 Semester 1 Postgraduate Taught Level 6 1 FHEQ level (Framework for Higher Education Qualifications) ' Masters/Integrated Masters P4 ' European Credit Transfer & Accumulation System Rating : 7.5 "Demystifying Solid Tumour Genomics" invites trainees to explore the intricate world of cancer development in lung, breast, ovarian, CNS, and sarcomas. Through a blend of theory and practice, the unit unveils the interplay between environmental and genetic factors, delves into the unique "genomic landscape" of each type, and critically analyses diagnostic techniques. Trainees delve into advanced monitoring strategies using genetic testing, and gain a comprehensive understanding of the patient's journey from sample collection to treatment planning. Emphasizing personalized medicine, the unit explores the role of individual genetic profiles in selecting optimal therapies. Additionally, the program highlights the impact of epigenetics and the importance of interdisciplinary collaboration for ensuring effective patient care. This comprehensive unit equips future healthcare professionals with the knowledge and skills to contribute significantly to personalized cancer treatment strategies. "Demystifying Solid Tumour Genomics" invites trainees to explore the intricate world of cancer development in lung, breast, ovarian, CNS, and sarcomas. Through a blend of theory and practice, the unit unveils the interplay between environmental and genetic factors, delves into the unique "genomic landscape" of each type, and critically analyses diagnostic techniques. Trainees delve into advanced monitoring strategies using genetic testing, and gain a comprehensive understanding of the patient's journey from sample collection to treatment planning. Emphasizing personalized medicine, the unit explores the role of individual genetic profiles in selecting optimal therapies. Additionally, the program highlights the impact of epigenetics and the importance of interdisciplinary collaboration for ensuring effective patient care. This comprehensive unit equips future healthcare professionals with the knowledge and skills to contribute significantly to personalized cancer treatment strategies. This module provides trainees with a detailed understanding of the molecular mechanisms of lung and ovarian cancer and associated genomic testing. 1. Integrate comprehensive understanding of the biological origins and incidence rates of lung, ovarian, breast, central nervous system (CNS), and sarcomas, elucidating the multifaceted aetiology of these solid tumours.2. Analyse the genomic mechanisms driving the development and progression of lung, ovarian, breast, CNS, and sarcomas, synthesizing knowledge of the intricate molecular pathways involved.3. Critically evaluate the selection and application of appropriate technologies, including sequencing and molecular techniques, for the comprehensive analysis and monitoring of solid tumours, considering factors such as resistance genomic aberrations and disease progression.4. Evaluate advanced testing strategies in the context of disease monitoring, metastasis, relapse, and resistance genomic aberrations, integrating knowledge to optimize clinical decision-making and patient outcomes.5. Apply integrated knowledge of the patient pathway for solid tumours, encompassing sampling, laboratory analysis, integrated reporting, and feedback mechanisms to enhance clinical management and patient care.6. Demonstrate an in-depth understanding of the clinical treatment pathway for solid tumours, emphasizing the role of precision medicine and personalized therapeutic approaches tailored to individual patient profiles.7. Apply comprehensive understanding of epigenetic changes and their impact on targeted therapies and treatment outcomes, recognizing their significance in optimizing therapeutic efficacy and patient response.8. Explain the critical importance of collaborative partnerships between Genomics and other clinical specialisms, highlighting their role in facilitating appropriate genomic investigations and enhancing the patient pathway for optimal clinical outcomes and patient care. Apply acquired knowledge to area of own healthcare practice to interpret and evaluate information regarding laboratory test results for patients with haematological malignancies.Interpret scientific data and summarise the key findings.Critically evaluate the scientific evidence supporting our understanding of haematological malignancies. Retrieve, manage and collate information from primary and secondary sourcesPresent information clearly in the form of verbal and written reports.Communicate complex ideas and arguments in a clear and concise and effective manner.Work effectively as an individual or part of a team. Student will develop capacity for self-learning and independent thinking and to utilise problem solving skills.Critically evaluate their personal performance both as an individual and within a teamDemonstrate skills in working collegiately and effectively with others as a member of a teamBe able to set priorities and link these with effective time management. Effectively utilise a range of information sourcesTeam-working skills and evaluating others performance in a positive and enriching mannerStudents will be introduced to interpretation of complex data for diagnosis of lung and ovarian cancer and will be able to convert into practical knowledge for use in the clinical context of individual and groups of patients. In this unit, we have adopted a flipped instructional model, leveraging technology to provide a rich learning experience. The primary mode of content delivery is through pre-recorded materials accessible via an e-learning platform. These resources offer students the flexibility to engage with the material at their own pace and convenience.Complementing the pre-recorded content, students will participate in live online events designed to enhance interaction and deepen understanding. These events include Team-Based Learning (TBL) sessions, question and answer sessions (Q&A), and select live lectures.Through this hybrid approach, students benefit from the best of both worlds: self-directed learning opportunities with the pre-recorded materials and collaborative engagement during live sessions. This dynamic combination fosters active participation, encourages critical thinking, and promotes a comprehensive understanding of the course material. 0 Other 40% 2 Written assignment (inc essay) 60% 1 hour MCQs 40%1x Written assessment 2,000 words 60% Feedback will be provided after all assignments as well as during the live events. BIOL66502 Pre-Requisite Compulsory N Lectures 30 0 120